Changes in vascular leakage and expression of angiopoietins in the corpus luteum during pregnancy in rats.
The present study investigates changes in blood vessel stability and its regulation in the corpus luteum (CL) during pregnancy in the rat. First, blood vessel stability in the CL was evaluated during pregnancy based on vascular leakage, which was quantified by the Evans blue assay. Vascular leakage was highest on day 3, thereafter decreased until day 15 and increased again on day 21. Secondly, to study the regulation of vascular leakage, the expression of angiopoietins was examined in the CL during pregnancy. Angiopoietin-1 (Ang-1) effects maturation and stabilization of newly formed blood vessels, while Ang-2 produces the opposite effect by allowing vascular remodeling. An immunohistochemical study showed both Ang-1 and Ang-2 expression in luteal cells. mRNA and protein levels of Ang-1 were significantly higher on days 12 and 15 than those on days 3 and 21, whereas there was no significant change in Ang-2 expression. Since estradiol contributes to CL development during mid-pregnancy, we finally studied whether estradiol regulates vascular leakage and angiopoietin expression. Rats undergoing hypophysectomy and hysterectomy (hypox-hect) on day 12 were treated with estradiol until day 15. Vascular leakage was increased and Ang-1 expression was decreased by hypox-hect, and these effects were completely reversed by estradiol treatment. In conclusion, blood vessel stability in the CL is likely to be associated with CL development and CL regression, and may be regulated by angiopoietins. Estradiol contributes to blood vessel stabilization in the CL during mid-pregnancy, which is associated with an increase in Ang-1 expression.
Matsuoka-Sakata
Aki
A
Division of Obstetrics and Gynecology, Department of Reproductive, Pediatric and Infectious Science, Yamaguchi University School of Medicine, Minamikogushi 1-1-1, Ube, 755-8505 Japan.
Tamura
Hiroshi
H
Asada
Hiromi
H
Miwa
Ichiro
I
Taketani
Toshiaki
T
Yamagata
Yoshiaki
Y
Sugino
Norihiro
N
D042682:Angiopoietins / Q000032:analysis*; D000803:Angiotensin I / Q000032:analysis / Q000235:genetics; D000804:Angiotensin II / Q000032:analysis / Q000235:genetics; D000818:Animals; D001808:Blood Vessels / Q000502:physiology*; D003287:Contrast Media; D003338:Corpus Luteum / Q000098:blood supply* / Q000737:chemistry*; D005070:Evans Blue; D005119:Extravasation of Diagnostic and Therapeutic Materials; D005260:Female; D007150:Immunohistochemistry / Q000379:methods; D008856:Microscopy, Fluorescence; D018919:Neovascularization, Physiologic; D011247:Pregnancy; D012333:RNA, Messenger / Q000032:analysis; D051381:Rats; D017207:Rats, Sprague-Dawley; D042787:Receptor, TIE-2 / Q000235:genetics; D020133:Reverse Transcriptase Polymerase Chain Reaction; D012269:Ribosomal Proteins / Q000235:genetics
D042682:Angiopoietins; D003287:Contrast Media; D012333:RNA, Messenger; D012269:Ribosomal Proteins; C050482:Rpl19 protein, rat; D000804:Angiotensin II; D005070:Evans Blue; D000803:Angiotensin I; D042787:Receptor, TIE-2